GRASS VALLEY, Calif., Jan. 18, 2011 /PRNewswire/ — Eigen, a
worldwide specialty developer of medical imaging systems and
software announced the completion of the company’s restructuring
plan designed to position Eigen for rapid expansion in the $5
billion urology medical device marketplace.
The company has successfully transitioned through a voluntary
restructuring process and is now positioned with a unified
management team and strong financial support. “With Eigen’s
restructuring complete, the company is now well positioned to seize
the promise of our breakthrough technology,” said Brian Burr,
CEO.
For the last three decades, the name Eigen has been synonymous
with high-definition imaging systems for cardiology and radiology
in many of the world’s finest hospitals. In addition, the company
has built strong relationships with major OEM customers.
Eigen has expanded its expertise in imaging technology to
urology by providing assistance with the very urgent need of
diagnosing prostate cancer. Artemis is the world’s first imaging
technology platform to generate true, navigational and quantifiable
3D prostate images from a standard 2D ultrasound image. Backed by
over twenty protective patents, Artemis provides urologists and
radiation oncologists a revolutionary new way to view and biopsy
the prostate.
About Eigen
Eigen is a world leader in the development of innovative
imaging devices and technology that today allow healthcare
professionals improve their ability to visualize, diagnose and
determine appropriate treatment pathways in over 4,000 hospitals
worldwide. Located at 13366 Grass Valley Ave., Grass Valley, CA
95945. Check us out at www.eigen.com.
‘/>”/>
SOURCE
